ArticleCancers2018

Cariprazine, A Dopamine D₂/D₃ Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer.

Noor Hussein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.